Chronic marijuana use has been increasingly linked to cardiovascular events, though reports of acute myocardial infarction in young adults without traditional risk factors remain limited. A 24-year-old man with a 9-year history of daily marijuana use presented with acute chest pain. Emergency evaluation revealed anterior ST-segment elevation myocardial infarction with 100% proximal left anterior descending coronary artery occlusion, treated successfully with percutaneous intervention. Intravascular ultrasound showed isolated plaque rupture in an otherwise normal coronary tree. This case highlights marijuana's potential role in precipitating acute coronary events in young adults without traditional risk factors, supported by intravascular imaging findings.
30 May 2025 in Methodist DeBakey Cardiovascular Journal
Methylenetetrahydrofolate reductase gene (MTHFR) mutations can lead to hyperhomocysteinemia, a known risk factor for venous thromboembolism. In some studies, the A1298C and C677T polymorphisms of the MTHFR gene have been linked to thrombosis, though their clinical significance remains debated. This case presents a detailed analysis of two premenopausal females who presented with pulmonary embolism and were subsequently diagnosed with the A1298C mutation, indicating a potential relation between the A1298C mutation of the MTHFR gene and the subsequent triggering events of thrombotic manifestations associated with raised levels of homocysteine. The varying clinical presentations and biochemical profiles underscore the complex relationship between genotype and phenotype in MTHFR-associated thrombophilias.
Cardiovascular disease remains the leading cause of global mortality with nearly 19 million deaths annually, while exponential growth in multimodal imaging, continuous monitoring, and electronic health record data has created analytical challenges exceeding traditional methods. This narrative review examines artificial intelligence (AI) and machine learning (ML) applications in cardiovascular medicine through a comprehensive literature analysis from 2019 to 2025, focusing on clinical validation and regulatory approvals. Current applications demonstrate significant clinical utility: automated ECG interpretation achieves > 90% accuracy in arrhythmia detection and predicts life-threatening arrhythmias up to two weeks before clinical onset; deep learning cardiac imaging analysis matches expert performance while reducing analysis time from 45 minutes to under 5 minutes; and ML risk prediction outperforms traditional scores with area under the curve values of 0.865 vs. 0.765. The FDA has approved 122 cardiology AI algorithms representing 14% of all clinical AI in the U.S. market, including ECG interpretation, echocardiographic measurement, and imaging analysis systems. Real-world implementations demonstrate 15–25% reductions in diagnostic errors and 20–30% faster emergency intervention times. However, substantial challenges persist: data quality limitations, algorithmic bias with 10–15% performance variation across populations, workflow integration barriers, and validation requirements. Future directions include multimodal systems, continuously learning algorithms, precision medicine applications, and equitable global implementation. Successful integration requires addressing limitations through diverse training datasets, transparent development, standardized validation, provider education, and maintaining physician autonomy. AI and ML represent powerful augmentation tools that, through evidence-based implementation, can transform cardiovascular care while preserving clinical expertise in decision-making.
5 February 2025 in Methodist DeBakey Cardiovascular Journal
A 76-year-old female with hypertension and hyperlipidemia was evaluated for incidental left ventricular calcification. Despite recent exertional chest pain, she was largely asymptomatic. Cardiac imaging revealed extensive endomyocardial calcifications without significant coronary artery stenosis. Laboratory tests excluded hypercalcemia, hyperparathyroidism, and sarcoidosis, leading to a diagnosis of idiopathic calcific cardiomyopathy. This case highlights the importance of comprehensive cardiac imaging in detecting subtle abnormalities, even in asymptomatic patients from non-tropical regions. It emphasizes considering both metastatic and dystrophic causes of endomyocardial calcification, regardless of geographical location. Given the patient’s asymptomatic status and the condition’s benign nature, a conservative management approach with regular monitoring was adopted. This case contributes to the limited literature on incidental endomyocardial calcification and may inform future strategies for similar presentations.
22 October 2024 in Catheterization and Cardiovascular Interventions